Farland Leslie V, Tamimi Rulla M, Eliassen A Heather, Spiegelman Donna, Collins Laura C, Schnitt Stuart J, Missmer Stacey A
Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA.
Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Avenue, Boston, MA, 02115, USA.
Breast Cancer Res Treat. 2016 Oct;159(3):545-52. doi: 10.1007/s10549-016-3957-y. Epub 2016 Sep 7.
Given the altered hormonal and inflammatory environment of women with endometriosis, several studies have suggested a positive association between endometriosis and breast cancer, although findings have been mixed. This study investigates the relationship between endometriosis and benign breast disease (BBD), benign lesions that are associated with an increased risk of breast cancer.
Among women in the Nurses' Health Study II followed from 1991-2003 (n = 76,393), we investigated the association between laparoscopically confirmed endometriosis and biopsy-confirmed BBD. Cox proportional hazard models, adjusted for a priori potential confounding factors, were used to calculate hazard ratios (HR) and 95 % confidence intervals (CI). Across follow-up, 2011 BBD biopsies were collected and centrally reviewed by study pathologists (nonproliferative = 675, proliferative = 1336). Effect modification by infertility history and use of screening mammography was investigated.
Endometriosis was associated with a modest increased risk of biopsy-confirmed BBD in crude and multivariable adjusted models (HR 1.20, 95 % CI 1.00-1.43). When evaluating subtypes of BBD, we did not see different associations for nonproliferative or proliferative BBD lesions, as endometriosis was associated with a modest increased risk for both (HR nonproliferative 1.15, 95 % CI 0.84-1.57; HR proliferative 1.22, 95 % CI 0.98-1.52). The association between endometriosis and proliferative BBD appeared strongest among women who had ever experienced infertility (HR 1.50, 95 % CI 1.12-2.03; P value, test for heterogeneity = 0.05). Sensitivity analyses investigating screening behaviors between those with and without endometriosis did not significantly alter results.
Endometriosis was associated with a modest increased risk of both proliferative and nonproliferative BBD, although future work should replicate this novel finding.
鉴于子宫内膜异位症女性的激素和炎症环境发生改变,多项研究表明子宫内膜异位症与乳腺癌之间存在正相关,尽管研究结果不一。本研究调查子宫内膜异位症与乳腺良性疾病(BBD)之间的关系,乳腺良性疾病是与乳腺癌风险增加相关的良性病变。
在1991年至2003年随访的护士健康研究II中的女性(n = 76,393)中,我们调查了腹腔镜确诊的子宫内膜异位症与活检确诊的BBD之间的关联。使用针对先验潜在混杂因素进行调整的Cox比例风险模型来计算风险比(HR)和95%置信区间(CI)。在整个随访期间,收集了2011例BBD活检样本,并由研究病理学家进行集中审查(非增殖性 = 675例,增殖性 = 1336例)。研究了不孕史和乳腺钼靶筛查的效应修正作用。
在粗模型和多变量调整模型中,子宫内膜异位症与活检确诊的BBD风险适度增加相关(HR 1.20,95% CI 1.00 - 1.43)。在评估BBD的亚型时,我们没有发现非增殖性或增殖性BBD病变有不同的关联,因为子宫内膜异位症与两者的风险适度增加都相关(HR非增殖性1.15,95% CI 0.84 - 1.57;HR增殖性1.22,95% CI 0.98 - 1.52)。子宫内膜异位症与增殖性BBD之间的关联在有过不孕经历的女性中似乎最强(HR 1.50,95% CI 1.12 - 2.03;P值,异质性检验 = 0.05)。调查有无子宫内膜异位症者筛查行为的敏感性分析未显著改变结果。
子宫内膜异位症与增殖性和非增殖性BBD的风险适度增加相关,尽管未来的研究应重复这一新颖发现。